高级检索
    陈碧, 张毛为, 孙宜田, 左丽娜, 张晓娇, 赵力, 陈昊. 前白蛋白和血小板与广泛期小细胞肺癌预后的关系[J]. 徐州医科大学学报, 2020, 40(9): 631-634. DOI: 10.3969/j.issn.2096-3882.2020.09.002
    引用本文: 陈碧, 张毛为, 孙宜田, 左丽娜, 张晓娇, 赵力, 陈昊. 前白蛋白和血小板与广泛期小细胞肺癌预后的关系[J]. 徐州医科大学学报, 2020, 40(9): 631-634. DOI: 10.3969/j.issn.2096-3882.2020.09.002
    Prognostic Value of Prealbumin and Platelet in Patients with S mall Cell Lung Cancer[J]. Journal of Xuzhou Medical University, 2020, 40(9): 631-634. DOI: 10.3969/j.issn.2096-3882.2020.09.002
    Citation: Prognostic Value of Prealbumin and Platelet in Patients with S mall Cell Lung Cancer[J]. Journal of Xuzhou Medical University, 2020, 40(9): 631-634. DOI: 10.3969/j.issn.2096-3882.2020.09.002

    前白蛋白和血小板与广泛期小细胞肺癌预后的关系

    Prognostic Value of Prealbumin and Platelet in Patients with S mall Cell Lung Cancer

    • 摘要: 目的 分析治疗前患者前白蛋白、血小板与广泛期小细胞肺癌(SCLC)患者预后的关系,探讨其对广泛期SCLC预后评估的价值.方法 选取2012年2月—2017年7月于徐州医科大学附属医院治疗的广泛期SCLC患者,共116例.收集患者的临床资料,包括性别、年龄、ECOG评分、以及治疗前的前白蛋白水平和血小板计数等.采用Log-rank检验和Cox比例风险模型分析治疗前患者前白蛋白、血小板与无进展生存(PFS)和总生存(OS)的关系.结果 治疗前患者前白蛋白水平与PFS显著相关(P=0.013),与OS显著相关(P=0.025).治疗前患者血小板计数与PFS无明显相关(P=0.093),但与OS显著相关(P=0.026).结论 治疗前患者前白蛋白和血小板是影响广泛期SCLC患者预后的因素.

       

      Abstract: ob<x>jective To analyze the data of prealbumin, platelet before treatment in extensive stage small cell lung cancer (SCLC) patients, and explore its prognostic value for patients with extensive-stage estimate small cell lung cancer. Methods This study?retrospectively analyzed 116 Patients with SCLC in the department?ofRespirtory Medicine in the Affiliated Hospital of Xuzhou Medical University from February 2012 ?to? July 201 7,who accepted the standardized EP chemotherapy. The reason of the death is the tumor. Excluding the impact of gender, age, comorbidities, ECOG score, the relationship between prealbumin and platelet ratio and patients’PFS and OS ?was?analyzed with Kaplan-Meier method and Cox?scale risk model. Results Prealbumin level before treatment in patients with PFS was significantly associated (P = 0.013), and significantly associated with the patients’ OS ( P = 0.025). Platelet before treatment was not significantly associated ( P = 0.093), but was significantly associated with the patients’ OS ( P = 0.026). Conclusion: The prealbumin and platelet before treatment was associated with the prognosis of extensive stage small cell lung cancer.

       

    /

    返回文章
    返回